Bionyra Pharma $165M
Bionyra Pharma launched with an oversubscribed 143 million euro Series A to advance its pipeline of antibodies for inflammatory diseases such as atopic dermatitis and IBD.
A quick read on the week, 17 deals and $440.9M raised. The highlights, not the whole list.
Bionyra Pharma launched with an oversubscribed 143 million euro Series A to advance its pipeline of antibodies for inflammatory diseases such as atopic dermatitis and IBD.
Patronus AI, founded by former Meta AI researchers, raised 50 million dollars to build digital worlds that stress test AI agents.
Leyden Labs raised funding, following selection for the EIC STEP Scale Up programme, to advance its intranasal protection platform through clinical development.
Isometric closed a 34 million euro Series A to expand its AI certification platform across the industrial certification market.
Tsuga raised a 30 million euro Series A to scale go-to-market and accelerate the rollout of its AI agent observability platform.
Thalia Therapeutics acquired US biotech Sanmirna Therapeutics for an initial consideration plus deferred milestone payments, bringing its clinical-stage AML microRNA candidate miRisten into Thalia's pipeline.